Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



NCI-COG Pediatric Match (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (Ulixertinib) in Patients with Tumors Harboring Activating MAPK Pathway Mutations

Multiple Cancer Types

Pediatric Lymphoma, Pediatric Solid Tumors, Pediatrics
II
Borinstein, Scott
NCT03698994
COGAPEC1621J

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: